Our team of clinicians has nationally-recognized expertise in the care of children, adolescents and young adults with the full array of pediatric cancer and blood disorder diagnoses. In addition, the New Jersey Pediatric Hematology and Oncology Research Center of Excellence (NJPHORCE) at Rutgers Cancer Institute includes physicians and scientists actively involved in cutting-edge research to improve the lives of children with these diagnoses. Our physicians and scientists offer children, adolescents, and young adults with cancer and blood disorders the most advanced pediatric hematology/oncology care in New Jersey.
To refer a patient to our Pediatric Hematology/Oncology Program, please call 844-CANCERNJ.
Explore Our Pediatric Hematology/Oncology Program →
As the state’s only NCI-designated Comprehensive Cancer Center, Rutgers Cancer Institute offers the most current and innovative diagnostic and treatment options. Our team of clinicians has experience and expertise in the diagnosis and treatment of all types of cancers and blood disorders that may affect children, adolescents and young adults. Many of our physician-scientists have achieved national recognition for leading clinical trials and/or laboratory research, with the objective of improving the lives of children with these diagnoses.
Why Refer to Our Pediatric Hematology/Oncology Program?
We provide specialized care at three convenient locations across the state. Our team includes nationally renowned physicians with expertise in treating a wide range of conditions, including leukemia, lymphoma, solid tumors, brain tumors, sickle cell anemia, and vascular anomalies. We are one of only two programs in the state offering advanced pediatric cellular therapies, such as CAR T-cell therapy, gene therapy and stem cell transplantation, and we also house a nationally recognized thrombosis and hemophilia center.
Our holistic approach to care supports both children with cancer and their families through a dedicated psychosocial team of psychologists, social workers, child life specialists, and educators. Each year, we manage over 6,000 pediatric patient visits, including hundreds of new cancer cases and blood disorder diagnoses. Additionally, we provide comprehensive follow-up care for nearly 500 cancer survivors through our long-term and late-effects clinic, ensuring continuity of care beyond treatment.
Resources for Physicians
Making Referrals
Our program’s physicians work closely with you to provide regular updates on your patient’s treatment and progress. To schedule a new patient appointment please call our Oncology Access Center at 844-CANCERNJ (844-226-2376).
Clinical Trials
We provide our patients access to the latest clinical trials, some of which are only available through NCI-designated Comprehensive Cancer Centers and in collaboration with industry and cooperative groups such as Children’s Oncology Group.
Centers for Exceptional Care
Our physicians at all of our locations work closely with you, the referring physician, to provide regular updates on your patient’s treatment and progress. Your patients will receive personalized care and attention in an atmosphere that is child-friendly and family-focused, close to home.
Bristol-Myers Squibb Children’s Hospital
at Robert Wood Johnson University Hospital, New Brunswick
Under the direction of Peter Cole, MD, Chief, Division of Pediatric Hematology/Oncology
The Valerie Fund Children’s Center for Cancer and Blood Disorders
at The Children’s Hospital of New Jersey at Newark Beth Israel Medical Center
Under the direction of Teena Bhatla, MD, Director, Pediatric Hematology/ Oncology
